Literature DB >> 3435824

GABAergic modulation of the analgesic effects of morphine microinjected in the ventral periaqueductal gray matter of the rat.

A Depaulis1, M M Morgan, J C Liebeskind.   

Abstract

The possibility that GABAergic neurons in the ventral periaqueductal gray matter modulate the analgesic effects of morphine microinjected into this brain area was investigated in the rat. Microinjection of 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin 3-ol (THIP) (0.4 microgram in 0.2 microliter), a GABA agonist, in the ventral periaqueductal gray matter significantly reversed the increase of tail-flick latency induced by a prior injection of morphine sulfate (4 micrograms in 0.2 microliter) at the same site. Conversely, microinjection in the same region of picrotoxin (10 ng in 0.2 microliter), a GABA antagonist, significantly potentiated the analgesic effect of the same dose of morphine. These results suggest the existence of GABAergic neurons that tonically inhibit periaqueductal gray output neurons involved in centrifugal pain inhibition. The analgesic effects of opiates may, at least in part, result from disinhibition of these GABAergic neurons.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3435824     DOI: 10.1016/0006-8993(87)91665-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  24 in total

1.  Mechanism Underlying the Analgesic Effect Exerted by Endomorphin-1 in the rat Ventrolateral Periaqueductal Gray.

Authors:  Tao Chen; Jing Li; Ban Feng; Rui Hui; Yu-Lin Dong; Fu-Quan Huo; Ting Zhang; Jun-Bin Yin; Jian-Qing Du; Yun-Qing Li
Journal:  Mol Neurobiol       Date:  2015-04-16       Impact factor: 5.590

2.  Midbrain central gray GABAA receptor activation enhances, and blockade reduces, sexual behavior in the female rat.

Authors:  M M McCarthy; D W Pfaff; S Schwartz-Giblin
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

Review 3.  GABA pharmacology: the search for analgesics.

Authors:  Kenneth E McCarson; S J Enna
Journal:  Neurochem Res       Date:  2014-02-15       Impact factor: 3.996

Review 4.  Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease.

Authors:  Christian Lüscher; Paul A Slesinger
Journal:  Nat Rev Neurosci       Date:  2010-04-14       Impact factor: 34.870

5.  Midbrain circuits for defensive behaviour.

Authors:  Philip Tovote; Maria Soledad Esposito; Paolo Botta; Fabrice Chaudun; Jonathan P Fadok; Milica Markovic; Steffen B E Wolff; Charu Ramakrishnan; Lief Fenno; Karl Deisseroth; Cyril Herry; Silvia Arber; Andreas Lüthi
Journal:  Nature       Date:  2016-06-01       Impact factor: 49.962

6.  Opioid presynaptic disinhibition of the midbrain periaqueductal grey descending analgesic pathway.

Authors:  Benjamin K Lau; Bryony L Winters; Christopher W Vaughan
Journal:  Br J Pharmacol       Date:  2020-02-15       Impact factor: 8.739

7.  Mechanism underlying increased neuronal activity in the rat ventrolateral periaqueductal grey by a mu-opioid.

Authors:  L C Chiou; L Y Huang
Journal:  J Physiol       Date:  1999-07-15       Impact factor: 5.182

8.  CC12, a P450/epoxygenase inhibitor, acts in the rat rostral, ventromedial medulla to attenuate morphine antinociception.

Authors:  Jennie L Conroy; Julia W Nalwalk; James G Phillips; Lindsay B Hough
Journal:  Brain Res       Date:  2013-01-05       Impact factor: 3.252

9.  Ligand-biased activation of extracellular signal-regulated kinase 1/2 leads to differences in opioid induced antinociception and tolerance.

Authors:  Erin N Bobeck; Susan L Ingram; Sam M Hermes; Sue A Aicher; Michael M Morgan
Journal:  Behav Brain Res       Date:  2015-10-20       Impact factor: 3.332

10.  Involvement of opioid receptors in N-methyl-D-aspartate-induced arterial hypertension in periaqueductal gray matter.

Authors:  S Maione; J Leyva; M Pallotta; L Berrino; V De Novellis; F Rossi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.